A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
Statistics in Medicine · 2024
DOI: 10.1002/sim.10205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2024. Verfasst von Samuel K Sarkodie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Bayes Theorem. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research (NIHR).
Abstract (Originalsprache)
This study presents a hybrid (Bayesian‐frequentist) approach to sample size re‐estimation (SSRE) for cluster randomised trials with continuous outcome data, allowing for uncertainty in the intra‐cluster correlation (ICC). In the hybrid framework, pre‐trial knowledge about the ICC is captured by placing a Truncated Normal prior on it, which is then updated at an interim analysis using the study data, and used in expected power control. On average, both the hybrid and frequentist approaches mitigate against the implications of misspecifying the ICC at the trial's design stage. In addition, both frameworks lead to SSRE designs with approximate control of the type I error‐rate at the desired level. It is clearly demonstrated how the hybrid approach is able to reduce the high variability in the re‐estimated sample size observed within the frequentist framework, based on the informativeness of the prior. However, misspecification of a highly informative prior can cause significant power loss. In conclusion, a hybrid approach could offer advantages to cluster randomised trials using SSRE. Specifically, when there is available data or expert opinion to help guide the choice of prior for the ICC, the hybrid approach can reduce the variance of the re‐estimated required sample size compared to a frequentist approach. As SSRE is unlikely to be employed when there is substantial amounts of such data available (ie, when a constructed prior is highly informative), the greatest utility of a hybrid approach to SSRE likely lies when there is low‐quality evidence available to guide the choice of prior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
- Statistics and Decision Sciences, Janssen R&D, High Wycombe, United Kingdom.
ORCID-Profile: Samuel K Sarkodie, James Ms Wason
Förderung
- National Institute for Health and Care Research (NIHR)
Zitieren
APA
Sarkodie, S. K., Wason, J. M., & Grayling, M. J. (2024). A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes. Statistics in Medicine. https://doi.org/10.1002/sim.10205
Vancouver
Sarkodie SK, Wason JM, Grayling MJ. A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes. Statistics in Medicine. 2024. doi:10.1002/sim.10205
BibTeX
@article{Sarkodie2024,
author = {Sarkodie, Samuel K and Wason, James Ms and Grayling, Michael J},
title = {A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10205}
}
EUVIMED